Shire Human Genetic Therapies, Inc. recalls VPRIV¿ (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human Genetic Therapies,
Recalled April 30, 2014 · FDA recall D-1251-2014 · Shire Human Genetic Therapies
Hazard
Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate. · FDA Class I
Units
8359 vials
Sold at
US Nationwide including Puerto Rico; Mexico, Columbia
Description
Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate.
Product
VPRIV¿ (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human Genetic Therapies, Inc. 300 Shire Way, Lexington, MA 02421. NDC: 54092-701-04.
Manufacturer(s)
Shire Human Genetic Therapies, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →